Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Xu, Zheng-Li  [Clear All Filters]
Journal Article
Ma R, Zhu D-P, Zhang X-H, Xu L-P, Wang Y, Mo X-D, Lv M, Zhang Y-Y, Cheng Y-F, Yan C-H, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transplant. 2024.
Xu Z-L, Xu L-P, Zhang Y-C, Zhou Y-H, Jiang E-L, Zhang J-P, Fu B, Ouyang G-F, Song X-M, Zhang X-J, et al. The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group. Haematologica. 2024.
Xu Z-L, Huang X-J. Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings. Expert Rev Hematol. 2021.
Xu Z-L, Xu L-P, Zhang Y-Y, Cheng Y-F, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, et al. Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation. Bone Marrow Transplant. 2023.
Wang Y, Liu Q-F, Wu D-P, Xu Z-L, Han T-T, Sun Y-Q, Huang F, Fan Z-P, Xu N, Chen F, et al. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC Med. 2024;22(1):176.
Xu Z-L, Cheng Y-F, Zhang Y-Y, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, Tang F-F, et al. The incidence, clinical outcome and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemia. Clin Transplant. 2020:e14160.
Shang Q-N, Yu X-X, Xu Z-L, Chen Y-H, Han T-T, Zhang Y-Y, Lv M, Sun Y-Q, Wang Y, Xu L-P, et al. Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection. Cell Mol Immunol. 2023.
Zhao X-Y, Yu X-X, Xu Z-L, Cao X-H, Huo M-R, Zhao X-S, Chang Y-J, Wang Y, Zhang X-H, Xu L-P, et al. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2019;3(24):4312-4325.
Xu L-P, Yu Y, Cheng Y-F, Zhang Y-Y, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, et al. Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation. Br J Haematol. 2021.
Xu Z-L, Huang X-J. COVID-19 & Allogeneic Transplant: Activity and Preventive Measures for Best Outcomes in China. Adv Cell Gene Ther. 2020:e94.
Xu L-P, Xu Z-L, Zhang X-H, Chen H, Chen Y-H, Han W, Chen Y, Wang F-R, Wang J-Z, Wang Y, et al. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia. Biol Blood Marrow Transplant. 2016.